1. |
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020, 382(8): 727-733.
|
2. |
World Health Organization. Coronavirus. [2021-02-03] https://www.who.int/health-topics/coronavirus.
|
3. |
国家卫生健康委员会, 国家中医药管理局. 新型冠状病毒肺炎诊疗方案 (试行第八版). [2020-08-19] http://www.nhc.gov.cn/xcs/zhengcwj/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a.shtml.
|
4. |
国务院应对新型冠状病毒肺炎疫情联防联控机制综合组. 新型冠状病毒肺炎防控方案 (第七版). [2020-09-11] http://www.gov.cn/xinwen/2020-09/15/content_5543680.htm.
|
5. |
Gupta R, Ghosh A, Singh AK, et al. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr, 2020, 14(3): 211-212.
|
6. |
Yamamoto N, Bauer G. Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation. Med Hypotheses, 2020, 144: 110160.
|
7. |
中华医学会呼吸病学分会, 中国医师协会呼吸医师分会. 中国成人2019冠状病毒病的诊治与防控指南. 中华医学杂志, 2021, 101(18): 1293-1356.
|
8. |
Islam OK, Al-Emran HM, Hasan MS, et al. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia. Transbound Emerg Dis, 2021, 68(2): 824-832.
|
9. |
Leung K, Shum MH, Leung GM, et al. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill, 2021, 26(1): 2002106.
|
10. |
Nikpouraghdam M, Jalali Farahani A, Alishiri G, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol, 2020, 127: 104378.
|
11. |
Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ, 2020, 369: m1985.
|
12. |
陈竹, 毛毅, 陈霆, 等. 成都379例新型冠状病毒肺炎的临床分析. 中国胸心血管外科临床杂志, 2021, 28(4): 388-395.
|
13. |
Joyce KE, Weaver SR, Lucas SJE. Geographic components of SARS-CoV-2 expansion: A hypothesis. J Appl Physiol (1985), 2020, 129(2): 257-262.
|
14. |
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016, 64(1): 73-84.
|
15. |
郝耀梅, 任建业. 慢性病患者用药依从性管理案例分析. 中国药物与临床, 2021, 21(4): 685-686.
|
16. |
Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: Results from the china hypertension survey, 2012-2015. Circulation, 2018, 137(22): 2344-2356.
|
17. |
Nikolich-Žugich J. The twilight of immunity: Emerging concepts in aging of the immune system. Nat Immunol, 2018, 19(1): 10-19.
|
18. |
Young BE, Fong SW, Chan YH, et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: An observational cohort study. Lancet, 2020, 396(10251): 603-611.
|
19. |
李闻, 郑宝璐, 于爱萍, 等. 新型冠状病毒IgM/IgG抗体在病程监测中的临床意义. 临床检验杂志, 2020, 38(6): 401-404.
|
20. |
马春娜, 吴双胜, 孙瑛, 等. 2020年1~7月北京市不同阶段新型冠状病毒肺炎疫情特征分析. 国际病毒学杂志, 2020, 27(6): 448-454.
|
21. |
陈晴, 黄涛, 杨铭, 等. 成都市不同年龄段新型冠状病毒肺炎患者临床特征及预后分析. 实用心脑肺血管病杂志, 2020, 28(12): 9-15.
|
22. |
Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev, 2020, 6(6): CD013652.
|
23. |
Shi P, Ren G, Yang J, et al. Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: A multicentre retrospective study. Epidemiol Infect, 2020, 148: e238.
|
24. |
代嫣嫣, 夏帅, 王茜, 等. 人类高致病性冠状病毒SARS-CoV和MERS-CoV的流行与突变—共性与个性特征的启示. 生命科学, 2016, 28(3): 357-366.
|
25. |
Khan MI, Khan ZA, Baig MH, et al. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLoS One, 2020, 15(9): e0238344.
|
26. |
Rabaan AA, Al-Ahmed SH, Sah R, et al. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob, 2020, 19(1): 40.
|
27. |
Dhama K, Patel SK, Pathak M, et al. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis, 2020, 37: 101755.
|